U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Lower limb hypertonia

MedGen UID:
375612
Concept ID:
C1845245
Finding
Synonyms: Hypertonia (in lower limbs); Hypertonia (lower limb); Hypertonia (lower limbs); Hypertonia of the lower limbs; Hypertonia, lower limbs
 
HPO: HP:0006895

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • Lower limb hypertonia

Conditions with this feature

Pelger-Huët anomaly
MedGen UID:
10617
Concept ID:
C0030779
Disease or Syndrome
An autosomal dominant inherited condition caused by mutations in the lamin B receptor gene. It is characterized by defects in the neutrophil lobulation, resulting in the presence of dumbbell-shaped neutrophils with bilobed nuclei in the peripheral blood smear.
Syndromic X-linked intellectual disability Claes-Jensen type
MedGen UID:
335139
Concept ID:
C1845243
Disease or Syndrome
Claes-Jensen type of X-linked syndromic intellectual developmental disorder (MRXSCJ) is characterized by impaired intellectual development with substantial clinical heterogeneity in affected males. However, males are usually reported to have short stature, microcephaly, hyperreflexia, and aggressive behavior. In rare cases, female carriers exhibit mildly impaired intellectual development or learning difficulties (summary by Guerra et al., 2020).
Hereditary spastic paraplegia 7
MedGen UID:
339552
Concept ID:
C1846564
Disease or Syndrome
Spastic paraplegia 7 (SPG7) is characterized by insidiously progressive bilateral leg weakness and spasticity. Most affected individuals have decreased vibration sense and cerebellar signs. Onset is mostly in adulthood, although symptoms may start as early as age 11 years and as late as age 72 years. Additional features including ataxia (gait and limbs), spastic dysarthria, dysphagia, pale optic disks, ataxia, nystagmus, strabismus, ptosis, hearing loss, motor and sensory neuropathy, amyotrophy, scoliosis, pes cavus, and urinary sphincter disturbances may be observed.
Spinocerebellar ataxia type 28
MedGen UID:
339941
Concept ID:
C1853249
Disease or Syndrome
Spinocerebellar ataxia type 28 (SCA28) is characterized by young-adult onset, very slowly progressive gait and limb ataxia resulting in coordination and balance problems, dysarthria, ptosis, nystagmus, and ophthalmoparesis. In most individuals, SCA28 presents as a loss of coordination of lower limbs (unsteadiness, gait ataxia). Less frequently, ptosis/ophthalmoplegia, dysarthria, or upper-limb incoordination may occur as the initial finding. The course of the disease is slowly progressive without impairment of functional autonomy even decades after onset.
Hereditary spastic paraplegia 10
MedGen UID:
349003
Concept ID:
C1858712
Disease or Syndrome
Spastic paraplegia-10 (SPG10) is an autosomal dominant neurologic disorder with variable manifestations. Some patients have onset of a 'pure' spastic paraplegia, with lower limb spasticity, hyperreflexia, extensor plantar responses, and variable involvement of the upper limbs beginning in childhood or young adulthood. Some patients show distal sensory impairment, which can be part of the 'pure' phenotype. However, some patients also show an axonal sensorimotor peripheral neuropathy with distal sensory impairment and distal muscle atrophy reminiscent of Charcot-Marie-Tooth disease type 2 (see, e.g., CMT2A, 118210). Rarely, patients with KIF5A mutations may have additional neurologic features, including parkinsonism or cognitive decline, consistent with a 'complicated' phenotype. Spastic paraplegia and peripheral neuropathy in isolation may represent extreme ends of the phenotypic spectrum of KIF5A mutations (summary by Goizet et al., 2009 and Crimella et al., 2012). For a general phenotypic description and a discussion of genetic heterogeneity of autosomal dominant spastic paraplegia, see SPG3A (182600).
Spastic ataxia 4
MedGen UID:
462275
Concept ID:
C3150925
Disease or Syndrome
A rare genetic autosomal recessive spastic ataxia disease with characteristics of the onset in early childhood of spastic paraparesis, cerebellar ataxia, dysarthria and optic atrophy. Caused by homozygous mutation in the MTPAP gene on chromosome 10p11.
Hereditary spastic paraplegia 53
MedGen UID:
761340
Concept ID:
C3539494
Disease or Syndrome
SPG53 is an autosomal recessive neurologic disorder characterized by onset in infancy of delayed motor development progressing to upper and lower limb spasticity with impaired walking. Affected individuals also show mild to moderate cognitive impairment (summary by Zivony-Elboum et al., 2012).
Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome
MedGen UID:
895943
Concept ID:
C4225229
Disease or Syndrome
Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome is a rare, genetic multiple congenital anomalies/dysmorphic syndrome characterized by global developmental delay, axial hypotonia, palate abnormalities (including cleft palate and/or high and narrow palate), dysmorphic facial features (including prominent forehead, hypertelorism, downslanting palpebral fissures, wide nasal bridge, thin lips and widely spaced teeth), and short stature. Additional manifestations may include digital anomalies (such as brachydactyly, clinodactyly, and hypoplastic toenails), a single palmar crease, lower limb hypertonia, joint hypermobility, as well as ocular and urogenital anomalies.
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome
MedGen UID:
903767
Concept ID:
C4225396
Disease or Syndrome
Arboleda-Tham syndrome (ARTHS) is an autosomal dominant disorder with the core features of impaired intellectual development, speech delay, microcephaly, cardiac anomalies, and gastrointestinal complications (summary by Kennedy et al., 2019).
Spastic paraplegia, intellectual disability, nystagmus, and obesity
MedGen UID:
924883
Concept ID:
C4284592
Disease or Syndrome
Spastic paraplegia, intellectual disability, nystagmus, and obesity (SINO) is an autosomal dominant neurologic disorder characterized by rapid growth in infancy, global developmental delay, spastic paraplegia, variable ophthalmologic defects, and dysmorphic facial features (summary by Josifova et al., 2016).
Hypermanganesemia with dystonia 2
MedGen UID:
934732
Concept ID:
C4310765
Disease or Syndrome
SLC39A14 deficiency is characterized by evidence between ages six months and three years of delay or loss of motor developmental milestones (e.g., delayed walking, gait disturbance). Early in the disease course, children show axial hypotonia followed by dystonia, spasticity, dysarthria, bulbar dysfunction, and signs of parkinsonism including bradykinesia, hypomimia, and tremor. By the end of the first decade they develop severe, generalized, pharmaco-resistant dystonia, limb contractures, and scoliosis, and lose independent ambulation. Cognitive impairment appears to be less prominent than motor disability. Some affected children have succumbed in their first decade due to secondary complications such as respiratory infections.
Ferro-cerebro-cutaneous syndrome
MedGen UID:
1658844
Concept ID:
C4751570
Disease or Syndrome
A rare genetic metabolic liver disease with characteristics of progressive neurodegeneration, cutaneous abnormalities including varying degrees of ichthyosis or seborrheic dermatitis, and systemic iron overload. Patients manifest with infantile-onset seizures, encephalopathy, abnormal eye movements, axial hypotonia with peripheral hypertonia, brisk reflexes, cortical blindness and deafness, myoclonus and hepato/splenomegaly, as well as oral manifestations including microdontia, widely spaced and pointed teeth with delayed eruption and gingival overgrowth.
Intellectual disability-hypotonic facies syndrome, X-linked, 1
MedGen UID:
1676827
Concept ID:
C4759781
Disease or Syndrome
Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is characterized by distinctive craniofacial features, genital anomalies, hypotonia, and mild-to-profound developmental delay / intellectual disability (DD/ID). Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short triangular nose, tented upper lip, and thick or everted lower lip with coarsening of the facial features over time. While all affected individuals have a normal 46,XY karyotype, genital anomalies comprise a range from hypospadias and undescended testicles, to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Alpha-thalassemia, observed in about 75% of affected individuals, is mild and typically does not require treatment. Osteosarcoma has been reported in a few males with germline pathogenic variants.
Spinocerebellar ataxia, autosomal recessive 27
MedGen UID:
1672866
Concept ID:
C5193058
Disease or Syndrome
Autosomal recessive spinocerebellar ataxia-27 (SCAR27) is an adult-onset neurologic disorder characterized by gait difficulties and other cerebellar signs, such as eye movement abnormalities, dysarthria, and difficulty writing. The disorder is progressive, and some patients may lose independent ambulation. Additional features include spasticity of the lower limbs and cognitive impairment. Brain imaging shows cerebellar atrophy (summary by Eidhof et al., 2018).
Leukodystrophy, hypomyelinating, 22
MedGen UID:
1787833
Concept ID:
C5543406
Disease or Syndrome
Hypomyelinating leukodystrophy-22 (HLD22) is a neurologic disorder characterized by global developmental delay with mildly impaired intellectual development and marked motor impairment with limited or no ability to walk and dysarthria. Affected individuals have limb spasticity with pyramidal signs, as well as nystagmus, hypermetropia, and astigmatism. Brain imaging shows hypomyelination and a delay in myelination, although serial imaging shows some progress in both the central and peripheral white matter regions (Riedhammer et al., 2021). For a general phenotypic description and a discussion of genetic heterogeneity of HLD, see 312080.
Aicardi-Goutieres syndrome 9
MedGen UID:
1794176
Concept ID:
C5561966
Disease or Syndrome
Aicardi-Goutieres syndrome-9 (AGS9) is a type I interferonopathy characterized by severe developmental delay and progressive neurologic deterioration. Patients present in infancy with irritability and spasticity. Brain imaging shows diffusely abnormal white matter, cerebral atrophy, and intracranial calcification. Premature death has been associated with renal and/or hepatic failure (Uggenti et al., 2020). For a general phenotypic description and discussion of genetic heterogeneity of Aicardi-Goutieres syndrome, see AGS1 (225750).
Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies
MedGen UID:
1823969
Concept ID:
C5774196
Disease or Syndrome
Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies (NEDITPO) is an autosomal recessive multiple congenital anomaly syndrome characterized by mild to moderate intellectual disability, dysmorphic facial features, intention tremor, dyspraxia, and vertical strabismus (Rahikkala et al., 2022).

Professional guidelines

PubMed

Olver J, Esquenazi A, Fung VS, Singer BJ, Ward AB; Cerebral Palsy Institute
Eur J Neurol 2010 Aug;17 Suppl 2:57-73. doi: 10.1111/j.1468-1331.2010.03128.x. PMID: 20633179

Recent clinical studies

Etiology

Chow JW, Stokic DS
Int J Rehabil Res 2023 Sep 1;46(3):238-247. Epub 2023 Jun 22 doi: 10.1097/MRR.0000000000000590. PMID: 37345412
Varvarousis DN, Martzivanou C, Dimopoulos D, Dimakopoulos G, Vasileiadis GI, Ploumis A
Toxicon 2021 Nov;203:74-84. Epub 2021 Oct 7 doi: 10.1016/j.toxicon.2021.09.020. PMID: 34626599
Dunne JW, Gracies JM, Hayes M, Zeman B, Singer BJ; Multicentre Study Group
Clin Rehabil 2012 Sep;26(9):787-97. Epub 2012 Feb 3 doi: 10.1177/0269215511432016. PMID: 22308557

Diagnosis

Zhang Q, Yang Q, Luo J, Zhou X, Yi S, Tan S, Qin Z
BMC Med Genomics 2024 Jan 31;17(1):44. doi: 10.1186/s12920-024-01805-x. PMID: 38297306Free PMC Article
Chow JW, Stokic DS
Int J Rehabil Res 2023 Sep 1;46(3):238-247. Epub 2023 Jun 22 doi: 10.1097/MRR.0000000000000590. PMID: 37345412
Bravo-Esteban E, Taylor J, Abián-Vicén J, Albu S, Simón-Martínez C, Torricelli D, Gómez-Soriano J
NeuroRehabilitation 2013;33(4):531-43. doi: 10.3233/NRE-131000. PMID: 24018366
Olver J, Esquenazi A, Fung VS, Singer BJ, Ward AB; Cerebral Palsy Institute
Eur J Neurol 2010 Aug;17 Suppl 2:57-73. doi: 10.1111/j.1468-1331.2010.03128.x. PMID: 20633179
White BD, Tsegaye M
Br J Neurosurg 2004 Jun;18(3):246-9. doi: 10.1080/02688690410001732670. PMID: 15327225

Therapy

Chow JW, Stokic DS
Int J Rehabil Res 2023 Sep 1;46(3):238-247. Epub 2023 Jun 22 doi: 10.1097/MRR.0000000000000590. PMID: 37345412
Varvarousis DN, Martzivanou C, Dimopoulos D, Dimakopoulos G, Vasileiadis GI, Ploumis A
Toxicon 2021 Nov;203:74-84. Epub 2021 Oct 7 doi: 10.1016/j.toxicon.2021.09.020. PMID: 34626599
Dunne JW, Gracies JM, Hayes M, Zeman B, Singer BJ; Multicentre Study Group
Clin Rehabil 2012 Sep;26(9):787-97. Epub 2012 Feb 3 doi: 10.1177/0269215511432016. PMID: 22308557
Olver J, Esquenazi A, Fung VS, Singer BJ, Ward AB; Cerebral Palsy Institute
Eur J Neurol 2010 Aug;17 Suppl 2:57-73. doi: 10.1111/j.1468-1331.2010.03128.x. PMID: 20633179

Prognosis

Zhang Q, Yang Q, Luo J, Zhou X, Yi S, Tan S, Qin Z
BMC Med Genomics 2024 Jan 31;17(1):44. doi: 10.1186/s12920-024-01805-x. PMID: 38297306Free PMC Article

Clinical prediction guides

Zhang Q, Yang Q, Luo J, Zhou X, Yi S, Tan S, Qin Z
BMC Med Genomics 2024 Jan 31;17(1):44. doi: 10.1186/s12920-024-01805-x. PMID: 38297306Free PMC Article
Varvarousis DN, Martzivanou C, Dimopoulos D, Dimakopoulos G, Vasileiadis GI, Ploumis A
Toxicon 2021 Nov;203:74-84. Epub 2021 Oct 7 doi: 10.1016/j.toxicon.2021.09.020. PMID: 34626599
Chow JW, Stokic DS
Arch Phys Med Rehabil 2019 Jun;100(6):1091-1101. Epub 2018 Nov 14 doi: 10.1016/j.apmr.2018.10.014. PMID: 30447195
Bravo-Esteban E, Taylor J, Abián-Vicén J, Albu S, Simón-Martínez C, Torricelli D, Gómez-Soriano J
NeuroRehabilitation 2013;33(4):531-43. doi: 10.3233/NRE-131000. PMID: 24018366
Dunne JW, Gracies JM, Hayes M, Zeman B, Singer BJ; Multicentre Study Group
Clin Rehabil 2012 Sep;26(9):787-97. Epub 2012 Feb 3 doi: 10.1177/0269215511432016. PMID: 22308557

Recent systematic reviews

Varvarousis DN, Martzivanou C, Dimopoulos D, Dimakopoulos G, Vasileiadis GI, Ploumis A
Toxicon 2021 Nov;203:74-84. Epub 2021 Oct 7 doi: 10.1016/j.toxicon.2021.09.020. PMID: 34626599

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...